These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 34685751)

  • 1. Involvement of Autophagy in Ageing and Chronic Cholestatic Diseases.
    Pinto C; Ninfole E; Benedetti A; Marzioni M; Maroni L
    Cells; 2021 Oct; 10(10):. PubMed ID: 34685751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FXR-dependent Rubicon induction impairs autophagy in models of human cholestasis.
    Panzitt K; Jungwirth E; Krones E; Lee JM; Pollheimer M; Thallinger GG; Kolb-Lenz D; Xiao R; Thorell A; Trauner M; Fickert P; Marschall HU; Moore DD; Wagner M
    J Hepatol; 2020 Jun; 72(6):1122-1131. PubMed ID: 32001325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of autophagy by bile acids and in cholestasis - CholestoPHAGY or CholeSTOPagy.
    Panzitt K; Fickert P; Wagner M
    Biochim Biophys Acta Mol Basis Dis; 2021 Feb; 1867(2):166017. PubMed ID: 33242590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nerve growth factor induced farnesoid X receptor upregulation modulates autophagy flux and protects hepatocytes in cholestatic livers.
    Tsai MS; Lee HM; Huang SC; Sun CK; Chiu TC; Chen PH; Lin YC; Hung TM; Lee PH; Kao YH
    Arch Biochem Biophys; 2020 Mar; 682():108281. PubMed ID: 32001246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Yangonin protects against cholestasis and hepatotoxity via activation of farnesoid X receptor in vivo and in vitro.
    Gao X; Fu T; Wang C; Ning C; Liu K; Liu Z; Sun H; Ma X; Huo X; Yang X; Zou M; Meng Q
    Toxicol Appl Pharmacol; 2018 Jun; 348():105-116. PubMed ID: 29660435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ileum-liver Farnesoid X Receptor signaling axis mediates the compensatory mechanism of 17α-ethynylestradiol-induced cholestasis via increasing hepatic biosynthesis of chenodeoxycholic acids in rats.
    Zhang F; Xi L; Duan Y; Qin H; Wei M; Wu Y; Li B; Zhou Y; Wu X
    Eur J Pharm Sci; 2018 Oct; 123():404-415. PubMed ID: 30077711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective activation of nuclear bile acid receptor FXR in the intestine protects mice against cholestasis.
    Modica S; Petruzzelli M; Bellafante E; Murzilli S; Salvatore L; Celli N; Di Tullio G; Palasciano G; Moustafa T; Halilbasic E; Trauner M; Moschetta A
    Gastroenterology; 2012 Feb; 142(2):355-65.e1-4. PubMed ID: 22057115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dexamethasone counteracts hepatic inflammation and oxidative stress in cholestatic rats via CAR activation.
    Gabbia D; Pozzo L; Zigiotto G; Roverso M; Sacchi D; Dalla Pozza A; Carrara M; Bogialli S; Floreani A; Guido M; De Martin S
    PLoS One; 2018; 13(9):e0204336. PubMed ID: 30252871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear receptors as therapeutic targets in cholestatic liver diseases.
    Zollner G; Trauner M
    Br J Pharmacol; 2009 Jan; 156(1):7-27. PubMed ID: 19133988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of autophagic flux by bile acids in hepatocytes.
    Manley S; Ni HM; Kong B; Apte U; Guo G; Ding WX
    Toxicol Sci; 2014 Feb; 137(2):478-90. PubMed ID: 24189133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Phospho-c-Jun N-Terminal Kinase Expression on hepatocyte Necrosis and Autophagy in the Cholestatic Liver.
    Kwak BJ; Choi HJ; Kim OH; Kim KH; You YK; Lee TY; Ahn J; Kim SJ
    J Surg Res; 2019 Sep; 241():254-263. PubMed ID: 31035140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic cholestatic liver diseases: clues from histopathology for pathogenesis.
    Pollheimer MJ; Fickert P; Stieger B
    Mol Aspects Med; 2014 Jun; 37():35-56. PubMed ID: 24141039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic Autophagy Deficiency Compromises Farnesoid X Receptor Functionality and Causes Cholestatic Injury.
    Khambu B; Li T; Yan S; Yu C; Chen X; Goheen M; Li Y; Lin J; Cummings OW; Lee YA; Friedman S; Dong Z; Feng GS; Wu S; Yin XM
    Hepatology; 2019 May; 69(5):2196-2213. PubMed ID: 30520052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Farnesoid X Receptor as Target for Therapies to Treat Cholestasis-Induced Liver Injury.
    Petrescu AD; DeMorrow S
    Cells; 2021 Jul; 10(8):. PubMed ID: 34440614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of autophagy in lung diseases and ageing.
    Zhang Y; Zhang J; Fu Z
    Eur Respir Rev; 2022 Dec; 31(166):. PubMed ID: 36543345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear receptors in acute and chronic cholestasis.
    Gonzalez-Sanchez E; Firrincieli D; Housset C; Chignard N
    Dig Dis; 2015; 33(3):357-66. PubMed ID: 26045270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. β-Defensin 1 Is Prominent in the Liver and Induced During Cholestasis by Bilirubin and Bile Acids
    Klag T; Thomas M; Ehmann D; Courth L; Mailänder-Sanchez D; Weiss TS; Dayoub R; Abshagen K; Vollmar B; Thasler WE; Stange EF; Berg CP; Malek NP; Zanger UM; Wehkamp J
    Front Immunol; 2018; 9():1735. PubMed ID: 30100908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of MAFG Dysregulation in Cholestatic Liver Injury and Development of Liver Cancer.
    Liu T; Yang H; Fan W; Tu J; Li TWH; Wang J; Shen H; Yang J; Xiong T; Steggerda J; Liu Z; Noureddin M; Maldonado SS; Annamalai A; Seki E; Mato JM; Lu SC
    Gastroenterology; 2018 Aug; 155(2):557-571.e14. PubMed ID: 29733835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effects of yangonin from an edible botanical Kava against lithocholic acid-induced cholestasis and hepatotoxicity.
    Kong Y; Gao X; Wang C; Ning C; Liu K; Liu Z; Sun H; Ma X; Sun P; Meng Q
    Eur J Pharmacol; 2018 Apr; 824():64-71. PubMed ID: 29427579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of nuclear receptors in the adaptive response to bile acids and cholestasis: pathogenetic and therapeutic considerations.
    Zollner G; Marschall HU; Wagner M; Trauner M
    Mol Pharm; 2006; 3(3):231-51. PubMed ID: 16749856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.